Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 2 , Pages 141-145 , February 2010

The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations

  • Tupur Rahman

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Room 306, Toronto, ON, Canada M5S 3E2
    • ,
  • Ameer Y. Taha

      Affiliations

    • Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
    • ,
  • Byung Jun Song

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Room 306, Toronto, ON, Canada M5S 3E2
    • ,
  • Sarah K. Orr

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Room 306, Toronto, ON, Canada M5S 3E2
    • ,
  • Zhen Liu

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Room 306, Toronto, ON, Canada M5S 3E2
    • ,
  • Chuck T. Chen

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Room 306, Toronto, ON, Canada M5S 3E2
    • ,
  • Richard P. Bazinet

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Room 306, Toronto, ON, Canada M5S 3E2
    • Corresponding Author InformationCorresponding author. Tel.: +14169468276; fax: +14169785882.

Received 29 July 2009 ,Accepted 5 November 2009.

References 

  1. Diau GY, Hsieh AT, Sarkadi-Nagy EA, et al. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Medicine. 2005;3:11
  2. Akbar MF, Calderon F, Wen Z. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:10858–10863
  3. Bazan NG. Synaptic signaling by lipids in the life and death of neurons. Molecular Neurobiology. 2005;31:219–230
  4. Rao JS, Ertley RN, Lee HJ, DeMar JC, Arnold JT, Rapoport SI, et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Molecular Psychiatry. 2007;12:36–46
  5. Axelrod J. Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochemical Society Transactions. 1990;18:503–507
  6. Innis SM. Dietary (n-3) fatty acids and brain development. The Journal of Nutrition. 2007;137:855–859
  7. Kothapalli KS, Anthony JC, Pan BS, Hsieh AT, Nathanielsz PW, Brenna JT. Differential cerebral cortex transcriptomes of baboon neonates consuming moderate and high docosahexaenoic acid formulas. PloS One. 2007;2:e370
  8. Calon F, Lim GP, Yang F, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 2004;43:633–645
  9. Phillis JW, Horrocks LA, Farooqui AA. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Research Reviews. 2006;52:201–243
  10. Sinclair AJ, Begg D, Mathai M, Weisinger RS. Omega 3 fatty acids and the brain: review of studies in depression. Asia Pacific Journal of Clinical Nutrition. 2007;16(Suppl 1):391–397
  11. Scott BL, Bazan NG. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proceedings of the National Academy of Sciences of the United States of America. 1989;86:2903–2907
  12. Lefkowitz W, Lim SY, Lin Y, Salem N. Where does the developing brain obtain its docosahexaenoic acid? Relative contributions of dietary alpha-linolenic acid, docosahexaenoic acid, and body stores in the developing rat. Pediatric Research. 2005;57:157–165
  13. Cunnane SC, Francescutti V, Brenna JT, Crawford MA. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids. 2000;35:105–111
  14. Chen CT, Green JT, Orr SK, Bazinet RP. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2008;79:85–91
  15. Hamilton JA, Hillard CJ, Spector AA, Watkins PA. Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders. Journal of Molecular Neuroscience. 2007;33:2–11
  16. M. Lagarde, N. Bernoud, N. Brossard et al., Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain, Journal of Molecular Neuroscience 16 (2001) 201-204;discussion 215-221.
  17. Kamp F, Hamilton JA. pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:11367–11370
  18. Kamp F, Zakim D, Zhang F, Noy N, Hamilton JA. Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry. 1995;34:11928–11937
  19. Mitchell RW, Edmundson CL, Miller DW, Hatch GM. On the mechanism of oleate transport across human brain microvessel endothelial cells. Journal of Neurochemistry. 2009;110:1049–1057
  20. Robinson PJ, Noronha J, DeGeorge JJ, Freed LM, Nariai T, Rapoport SI. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Research. 1992;17:187–214
  21. Chen CT, Liu Z, Ouellet M, Calon F, Bazinet RP. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2009;80:157–163
  22. M. Ouellet, V. Emond, C.T. Chen et al., Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study, Neurochemistry International. 55 (2009) 476–482.
  23. Edmond J, Higa TA, Korsak RA, Bergner EA, Lee WN. Fatty acid transport and utilization for the developing brain. Journal of Neurochemistry. 1998;70:1227–1234
  24. Innis SM, Sprecher H, Hachey D, Edmond J, Anderson RE. Neonatal polyunsaturated fatty acid metabolism. Lipids. 1999;34:139–149
  25. Marbois BN, Ajie HO, Korsak RA, Sensharma DK, Edmond J. The origin of palmitic acid in brain of the developing rat. Lipids. 1992;27:587–592
  26. Polozova A, Gionfriddo E, Salem N. Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2006;75:183–190
  27. Spector AA. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. Journal of Molecular Neuroscience. 2001;16:159–165discussion 215-121
  28. Hanaka S, Abe T, Itakura H, Matsumoto A. Gene expression related to cholesterol metabolism in mouse brain during development. Brain & Development. 2000;22:321–326
  29. Hofmann SL, Russell DW, Goldstein JL, Brown MS. mRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits. Proceedings of the National Academy of Sciences of the United States of America. 1987;84:6312–6316
  30. Meresse S, Delbart C, Fruchart JC, Cecchelli R. Low-density lipoprotein receptor on endothelium of brain capillaries. Journal of Neurochemistry. 1989;53:340–345
  31. Gosselet F, Candela P, Sevin E, et al. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Research. 2009;1249:34–42
  32. Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. Journal of Molecular Neuroscience. 2001;16:181–193discussion 215-121
  33. Chen CT, Ma DWL, Kim JH, Mount HTJ, Bazinet RP. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. Journal of Lipid Research. 2008;49:147–152
  34. Carter CJ. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochemistry International. 2007;50:12–38
  35. Taha AY, Chen CT, Liu Z, Kim JH, Mount HTJ, Bazinet RP. Brainstem concentrations of cholesterol are not influenced by genetic ablation of the low-density lipoprotein receptor. Neurochemical Research. 2008;34:311–315
  36. Dietschy JM, Turley SD. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. Journal of Lipid Research. 2004;45:1375–1397
  37. Jurevics H, Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. Journal of Neurochemistry. 1995;64:895–901
  38. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:9252–9256
  39. Wyne KL, Pathak K, Seabra MC, Hobbs HH. Expression of the VLDL receptor in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:407–415
  40. Vancassel S, Aïd S, Pifferi F, Morice E, Nosten-Bertrand M, Chalon S, et al. Cerebral asymmetry and behavioral lateralization in rats chronically lacking n-3 polyunsaturated fatty acids. Biological Psychiatry. 2005;58:805–811
  41. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, et al. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. Journal of Biological Chemistry. 2002;277:39944–39952
  42. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, et al. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell. 1999;97:689–701
  43. Dietschy JM, Turley SD. Thematic review series: brain lipids cholesterol metabolism in the central nervous system during early development and in the mature animal. Journal of Lipid Research. 2004;45:1375–1397
  44. Kovanen PT, Basu SK, Goldstein JL, Brown MS. Low density lipoprotein receptors in bovine adrenal cortex II, low density lipoprotein binding to membranes prepared from fresh tissue. Endocrinology. 1979;104:610–616
  45. Kovanen PT, Faust JR, Brown MS, Goldstein JL. Low density lipoprotein receptors in bovine adrenal cortex I. Receptormediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured adrenocortical cells. Endocrionology. 1979;104:599–609
  46. Canadian Council on Animal Care. Guide to the Care and Use of Experimental Animals, Ottawa, 1993.
  47. Rapoport. SI. Blood-Brain Barrier in Physiology and Medicine. New York: Raven Press; 1976;
  48. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Human Development. 1979;3:79–83
  49. Ma K, Langenbach R, Rapoport SI, Basselin M. Altered brain lipid composition in cyclooxygenase-2 knockout mouse. Journal of Lipid Research. 2007;48:848–854
  50. Ward G, Woods J, Reyzer M, Salem N. Artificial rearing of infant rats on milk formula deficient in n-3 essential fatty acids: a rapid method for the production of experimental n-3 deficiency. Lipids. 1996;31:71–77
  51. Lee HJ, Rao JS, Chang L, Rapoport SI, Bazinet RP. Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder. Psychopharmacology. 2007;193:467–474
  52. H.J. Lee, J.S. Rao, S.I. Rapoport, R.P. Bazinet, Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism, Prostaglandins, leukotrienes, and essential fatty acids 77 (2007), 239–246.
  53. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry. 1957;226:497–509
  54. Adams ML, Sullivan DM, Smith RL, Richter EF. Evaluation of direct saponification method for determination of cholesterol in meats. Journal of Assocication of Official Analytical Chemists. 1986;69:844–846
  55. Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biological Psychiatry. 2006;59:401–407
  56. Levant B, Ozias MK, Carlson SE. Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. The Journal of Nutrition. 2007;137:130–134
  57. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature. 1997;387:414–417
  58. Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biological Psychiatry. 2006;59:401–407
  59. Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. Psychopharmacology. 2005;182:180–185
  60. Lee HJ, Rao JS, Ertley RN, et al. Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. Psychopharmacology. 2007;190:103–115
  61. Lee HJ, Rao JS, Chang L, Rapoport SI, Bazinet RP. Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. Journal of Lipid Research. 2008;49:162–168
  62. Chang MC, Grange E, Rabin O, et al. Lithium decreases turnover of arachidonate in several brain phospholipids. Neuroscience letters. 1996;220:171–174
  63. Contreras MA, Chang MC, Kirkby D, Bell JM, Rapoport SI. Reduced palmitate turnover in brain phospholipids of pentobarbital-anesthetized rats. Neurochemical Research. 1999;24:833–841
  64. DeMar JC, Lee HJ, Ma K, et al. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochimica et Biophysica Acta. 1761;2006:1050–1059
  65. Golovko MY, Murphy EJ. Uptake and metabolism of plasma-derived erucic acid by rat brain. Journal of Lipid Research. 2006;47:1289–1297
  66. Demar JC, Ma K, Chang L, Bell JM, Rapoport SI. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. Journal of Neurochemistry. 2005;94:1063–1076
  67. Igarashi M, DeMar JC, Ma K, et al. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. Journal of Lipid Research. 2007;48:1150–1158
  68. Rapoport SI, Rao JS, Igarashi M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2007;77:251–261
  69. DeMar JC, Ma K, Bell JM, Rapoport SI. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. Journal of Neurochemistry. 2004;91:1125–1137
  70. Barr AM, Fish KN, Markou A. The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. Neuropharmacology. 2007;52:1114–1123
  71. Fedorova I, Salem N. Omega-3 fatty acids and rodent behavior. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2006;75:271–289
  72. Maekawa N, Takashima M, Matsumata , et al. Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PloS One. 2009;4:e5085
  73. Bu G. Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family. Current Opinion in Lipidology. 1998;9:149–155

PII: S0952-3278(09)00197-5

doi: 10.1016/j.plefa.2009.11.003

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 2 , Pages 141-145 , February 2010

Article Tools